Author:
Findling Robert L.,Candler Shawn A.,Nasser Azmi F.,Schwabe Stefan,Yu Chungping,Garcia-Olivares Jennie,O’Neal Welton,Newcorn Jeffrey H.
Publisher
Springer Science and Business Media LLC
Subject
Pharmacology (medical),Psychiatry and Mental health,Neurology (clinical)
Reference91 articles.
1. Mallion KB, Todd AH, Turner RW, Bainbridge JG, Greenwood DT, Madinaveitia J, et al. 2-(2-Ethoxyphenoxymethyl)tetrahydro-1,4-oxazine hydrochloride, a potential psychotropic agent. Nature. 1972;238:157–8.
2. Pinder RM, Brogden RN, Speight TM, Avery GS. Viloxazine: a review of its pharmacological properties and therapeutic efficacy in depressive illness. Drugs. 1977;13:401–21.
3. Renfordt E, Busch H, Fähndrich E, Müller-Oerlinghausen B. Studies on a novel antidepressant (viloxazin) by means of time-series analysis of TV data. Arzneimittelforschung. 1976;26(6):1114–6.
4. Marsh W. Viloxazine. In: Enna SJ, Bylund DB, editors. xPharm: the comprehensive pharmacology reference. Amsterdam: Elsevier Inc; 2007.
5. National Center for Biotechnology Information, PubChem database. Viloxazine, CID = 5666. https://pubchem.ncbi.nlm.nih.gov/compound/Viloxazine. Accessed 17 Jan 2019.
Cited by
37 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献